Clinical Training Schedule
Below is an approximate breakdown of a sample training schedule:
|Block Schedule, approximate: (4-week blocks)||Year 1||Year 2||Year 3|
|UH Oncology Consults||1||0||1|
|UH Hematology Consults||2||1||1|
|UH Malignant Hematology||2||1||0|
Outpatient Clinical Training
The outpatient clinical training is composed of two components:
1) Continuity Clinics: Outpatient clinical training occurs at one of the three training hospitals' outpatient practices, which may be disease-focused subspecialty clinics or general hematology and oncology teaching clinics. Most of our fellows are assigned to a general hematology/oncology clinic panel at MetroHealth or the VA. This continuity clinic and patient panel is maintained by the fellow during the entire fellowship.
2) Subspecialty Training Clinics: In addition to their continuity clinic experience, fellows are mentored by disease-focused expert faculty at the UH Seidman Cancer Center and gain expertise in bone marrow aspirate and biopsy during the "Outpatient Rotation during first and second year; additionally, during the second year of fellowship, fellows rotate in three-month blocks of subspecialty clinics in major areas of hematology and oncology, including:
- Benign hematology
- Head and neck
- Malignant hematology
- Stem cell transplant
- Thoracic oncology
In the third year, clinics are focused on the fellow's major area of clinical focus.
Continuity Clinic Experiences
Fellows typically have a one-half day of clinic per week during the first year at the continuity clinic, two half-day clinics at the continuity clinic and subspecialty clinic blocks in the second year and one to three half-day clinics in the third year, depending on career objectives. Third-year fellows who are engaged in intensive clinical or laboratory research will generally limit their outpatient clinics, with clinical experience focused in an area that corresponds to their research interest, while those seeking broadly based-training for eventual clinical practice will continue rotting through all of the major disease areas in benign and malignant hematology and medical oncology.